Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in a Primary Refractory t-AML Patient

John Godwin; Carmen Ballesteros-Merino; Carlo B Bifulco; Helene Lelièvre; Jon Wigginton; Jan K Davidson-Moncada; Bernard Fox

doi:10.1182/BLOOD-2018-99-118522

Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in a Primary Refractory t-AML Patient

John Godwin
, Carmen Ballesteros-Merino
, Carlo B Bifulco
, Helene Lelièvre
, Jon Wigginton
, Jan K Davidson-Moncada
, Bernard Fox

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	132
DOIs	https://doi.org/10.1182/BLOOD-2018-99-118522
State	Published - Nov 29 2018

Disciplines

Medicine and Health Sciences
Oncology

Access to Document

10.1182/BLOOD-2018-99-118522License: Unspecified

Cite this

@article{0d334d90a1cf424abd53fbf8bb801ff5,

title = "Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart{\textregistered} Protein, in a Primary Refractory t-AML Patient",

author = "John Godwin and Carmen Ballesteros-Merino and Bifulco, \{Carlo B\} and Helene Leli{\`e}vre and Jon Wigginton and Davidson-Moncada, \{Jan K\} and Bernard Fox",

note = "616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster III | John Godwin, Carmen Ballesteros-Merino, Carlo B Bifulco, Helene Leli{\`e}vre, Jon Wigginton, Jan K Davidson-Moncada, Bernard Fox; Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart {\textregistered} Protein, in a Primary Refractory t-AML Patient.",

year = "2018",

month = nov,

day = "29",

doi = "10.1182/BLOOD-2018-99-118522",

language = "American English",

volume = "132",

journal = "Blood",

}

TY - JOUR

T1 - Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in a Primary Refractory t-AML Patient

AU - Godwin, John

AU - Ballesteros-Merino, Carmen

AU - Bifulco, Carlo B

AU - Lelièvre, Helene

AU - Wigginton, Jon

AU - Davidson-Moncada, Jan K

AU - Fox, Bernard

N1 - 616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster III | John Godwin, Carmen Ballesteros-Merino, Carlo B Bifulco, Helene Lelièvre, Jon Wigginton, Jan K Davidson-Moncada, Bernard Fox; Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart ® Protein, in a Primary Refractory t-AML Patient.

PY - 2018/11/29

Y1 - 2018/11/29

UR - https://ashpublications.org/blood/article/132/Supplement%201/4065/265240/Bone-Marrow-T-Cell-Changes-By-Multiplex-IHC-after

U2 - 10.1182/BLOOD-2018-99-118522

DO - 10.1182/BLOOD-2018-99-118522

M3 - Article

VL - 132

JO - Blood

JF - Blood

ER -

Bone Marrow T Cell Changes By Multiplex IHC after Treatment with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in a Primary Refractory t-AML Patient

Disciplines

Access to Document

Other files and links

Cite this